|
SPG11 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.56631000000074E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.05830000000029E-05 |
| Normal-vs-Stage2 |
2.137600E-02 |
| Normal-vs-Stage3 |
2.00320000000032E-05 |
| Normal-vs-Stage4 |
9.50530000000116E-05 |
| Stage1-vs-Stage2 |
4.944000E-01 |
| Stage1-vs-Stage3 |
2.204800E-01 |
| Stage1-vs-Stage4 |
2.979200E-01 |
| Stage2-vs-Stage3 |
1.732760E-01 |
| Stage2-vs-Stage4 |
1.980570E-01 |
| Stage3-vs-Stage4 |
9.334400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.56926000000057E-05 |
| Normal-vs-AfricanAmerican |
1.585040E-01 |
| Normal-vs-Asian |
1.630240E-04 |
| Caucasian-vs-AfricanAmerican |
1.482040E-01 |
| Caucasian-vs-Asian |
5.305000E-01 |
| AfricanAmerican-vs-Asian |
9.884300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.364440E-04 |
| Normal-vs-Female |
1.80906999999175E-05 |
| Male-vs-Female |
7.520400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.979300E-04 |
| Normal-vs-Age(41-60Yrs) |
4.95190000004975E-06 |
| Normal-vs-Age(61-80Yrs) |
3.216100E-04 |
| Normal-vs-Age(81-100Yrs) |
8.967000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.373800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.142000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.188300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.475800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.653700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.130000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.819800E-01 |
| Classical-VS-Follicular |
8.544800E-01 |
| Classical-VS-Other |
5.566400E-01 |
| Classical-VS-Normal |
2.28049999999591E-05 |
| Tall-VS-Follicular |
9.816000E-01 |
| Tall-VS-Other |
5.166200E-01 |
| Tall-VS-Normal |
7.944000E-03 |
| Follicular-VS-Other |
5.621600E-01 |
| Follicular-VS-Normal |
1.241050E-03 |
| Other-VS-Normal |
2.956200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.53529999996827E-06 |
| Normal-vs-N1 |
1.992770E-04 |
| N0-vs-N1 |
6.116000E-01 |
|
|
